Therapeutic Intervention
After hospitalization of the patient in the stroke unit, antithrombotic
and neuroprotective therapy was initiated: 30ml Cerebrolysin
intravenously once daily for 16 days and oral administration of
high-dose aspirin (326 mg) once daily for 9 days, followed by low dose
Aspirin (75 mg). In addition, the patient received basic stroke therapy
in accordance with the AHA-ASA recommendations and the clinical protocol
of the Ministry of Health of the Republic of Belarus. For the
concomitant hypertension, candesartan (8 mg once daily) and indapamide
(2.5 mg once daily) were administered. Due to the fact that the patient
has a very high risk of developing fatal cardiovascular diseases,
atorvastatin (40 mg once daily) was prescribed to lower cholesterol
levels. Furthermore, the patient received gastroprotection, with 20mg
pantoprazole once daily during the entire course of treatment.